LMH STRATEGIC SOLUTIONS

Lobbying for ALKERMES, INC. · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $40,000.00 income · posted Apr 18, 2025

Bills named in this filing 1

Lobbying activity 1

Medicare/Medicaid

Medicare/Medicaid issues. H.R.946 - ORPHAN Cures Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.